ARUP launches multiple myeloma MRD assay by spectral flow cytometry
July 24, 2026—ARUP Laboratories has launched the ARUP Clarispect Multiple Myeloma MRD by Spectral Flow Cytometry.
Thursday, August 20, 2026. 12 PM-1:30 PM ET
Hear from an expert in HER2 IHC whose work has contributed to current scoring guidelines.
Webinar presenter Josef Ruschoff, MD, PhD, Former Chief Medical Officer and Co-Founder of Targos, Senior Consultant of Discovery Life Sciences, Kassel, Germany.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
To be rescheduled to a future date
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
July 24, 2026—ARUP Laboratories has launched the ARUP Clarispect Multiple Myeloma MRD by Spectral Flow Cytometry.
July 23, 2026—Seegene USA has received FDA emergency use authorization for the Allplex HSV-1&2/VZV/MPXV assay.
July 22, 2026—Cepheid will unveil the third generation of the GeneXpert system on Tuesday, July 28, at the Association for Diagnostics and Laboratory Medicine Annual Scientific Meeting.
July 21, 2026—The Florida Society of Pathologists 5th Multidisciplinary Interactive Precision Medicine Symposium will take place Aug. 22 at Moffitt Cancer Center, 12902 USF Magnolia Drive, in Tampa, Fla.
July 20, 2026—Zepto Life Technology has introduced FungiFlex Pneumocystis jirovecii, a targeted plasma cell-free DNA liquid biopsy assay for the detection of P. jirovecii, and the FungiFlex Mold Plus panel, which combines invasive mold detection with P. jirovecii in a single plasma-based test order.
July 15, 2026—Leica Biosystems, an operating company of Danaher, has entered into a definitive agreement to acquire privately held StatLab Medical Products, a global developer and manufacturer of anatomic pathology products, from Linden Capital Partners and Audax Private Equity. Following the closing, StatLab will become part of Leica Biosystems. StatLab provides a broad portfolio of products across the preanalytical and analytical histology workflow, from specimen collection and tissue processing through slide preparation and staining. Built on a strong reputation for
July 10, 2026—Seegene has launched the Global Million Clinical Study, which aims to evaluate the clinical utility and potential impact of syndromic PCR testing using real-world data.
July 9, 2026—The FDA has cleared the Visby Medical Flu and COVID-19 at-home PCR test.
July 7, 2026—Bio-Rad Laboratories launched its QX700 system-compatible Vericheck ddPCR kit portfolio for quality control workflows in advanced cell and gene therapy development and other biopharma applications.
July 6, 2026—Epredia has launched sales of the SlideMate thermal slide printer, engineered to help clinical laboratories protect tissue samples, strengthen sample traceability, and streamline workflow efficiency during cancer diagnosis.